financial results

DBV Technologies reports 296M shares outstanding and 296M voting rights as of March 31, 2026, with updates on VIASKIN® Peanut Patch clinical programs.

DBV Technologies files 2025 annual report disclosing 296M shares outstanding, 295.9M voting rights as VIASKIN Peanut development continues.

Roper Technologies announced Q1 2026 earnings release on April 23 and approved a $0.91 per share dividend payable April 22.

NTIC will release fiscal 2026 Q2 earnings April 9 pre-market, with a 9 a.m. ET conference call for investor Q&A.

Class action lawsuit filed against Navan alleges IPO documents omitted increased marketing spend and slowing revenue. Stock fell 11.89% after Q1 loss.

The Portnoy Law Firm investigates $ICHR following a 23.2% stock collapse tied to Q1 2025 earnings miss and margin compression.

Stryker will announce first quarter fiscal 2026 results April 30, with webcast discussion at 4:30 p.m. ET following press release.

Pomerantz LLP files securities fraud class action against Camping World Holdings ($CWH) following disclosure of declining revenues, margin compression, and dividend suspension. Investors must act by May 11, 2026.

BrainStorm Cell Therapeutics reported $10.3M net loss for 2025 while securing $2M financing and advancing NurOwn into Phase 3b ALS study following FDA clearance.

Co-Diagnostics ($CODX) posted $0.6M revenue and $46.9M net loss in 2025, down from prior year, amid strategic joint ventures and pipeline advancement.

Investview reported steep 2025 losses amid revenue decline, though pursuing strategic pivots in fintech and bitcoin mining with cost reductions.

$IDTA maintains profitability with $1.34M revenue and $99K net income in 2025, despite year-over-year declines, as it strengthens balance sheet for international growth.

Sanoma reports €1.3B revenue with 14.4% adjusted operating margin in 2025, completing share buyback while advancing ESG compliance.

Verizon will report Q1 2026 earnings April 27, 2026, with webcast at 8:30 a.m. ET and financial materials released at 7:00 a.m. ET.

CN Railway will release first-quarter 2026 financial results on April 29, 2026, with management conference call at 8:30 AM ET.

Oatly announces Q1 2026 earnings call for April 29 and invests $16M in Swedish production capacity to meet global demand growth.

Monopar reports $13.7M net loss, $140.4M cash reserves funding operations through 2027. Company plans mid-2026 NDA submission for Wilson disease treatment ALXN1840.

$UCB schedules Q1 2026 earnings release for April 21, 2026. Regional bank operates 199 offices across six southeastern states with $28 billion in assets.

Werewolf Therapeutics seeks strategic alternatives including potential sale or merger. Company reports improved 2025 financials, reduced losses, and $57.1M cash reserves.

GAM reported CHF 74.2M net loss in FY2025, improved from prior year, but assets fell to CHF 12.5B amid CHF 3.7B outflows.